SCHEMBL8185296

SCHEMBL8185296

O=C(O)C(F)(F)c1cccc2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
ACP3 P15309 1/20 0.49
NR4A1 P22736 1/20 0.47
NR4A2 P43354 1/20 0.47
NR4A3 Q92570 1/20 0.47
ALDH1A1 P00352 2/20 0.45
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 2/20 0.43
KIF11 P52732 1/20 0.42
CNR2 P34972 1/20 0.42
CDC25B P30305 1/20 0.42
KCNJ11 Q14654 3/20 0.41
PTPRC P08575 1/20 0.41
WDR5 P61964 1/20 0.40
CTNNB1 P35222 1/20 0.40
ABCC9 O60706 1/20 0.40
ABCC8 Q09428 1/20 0.40
KCNJ8 Q15842 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30707929 1.00 KDM4E (0.49) KDM4EMEN1KMT2AACP3NR4A1
SCHEMBL16147542 0.84 ACP3 (0.60) KDM4EMEN1KMT2AACP3NR4A1
SCHEMBL28705859 0.83 KDM4E (0.47) KDM4EMEN1KMT2AACP3NR4A1
SCHEMBL29081148 0.81 KDM4E (0.50) KDM4EMEN1KMT2AACP3NR4A1
SCHEMBL13199346 0.81 CES1 (0.46) ALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL3209247 0.80 KDM4E (0.45) KDM4EMEN1KMT2AACP3NR4A1
SCHEMBL17289035 0.80 KDM4E (0.44) KDM4EMEN1KMT2AACP3NR4A1
SCHEMBL22534073 0.79 HSD17B10 (0.36) KDM4EMEN1KMT2AACP3NR4A1
SCHEMBL31515165 0.79 HSD17B10 (0.36) KDM4EMEN1KMT2AACP3NR4A1
SCHEMBL4592642 0.78 CYP2C9 (0.52) KDM4EMEN1KMT2AACP3NR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4340614-A1 WEED CONTROL METHOD Syngenta Crop Protection AG (CH) 2024-03-27 EP disclosed
US-20230131899-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL THERAPEUTICS, INC. (US) 2023-04-27 US disclosed
US-20230131899-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL THERAPEUTICS, INC. (US) 2023-04-27 US disclosed
WO-2022243155-A1 WEED CONTROL METHOD SYNGENTA CROP PROTECTION AG (CH) 2022-11-24 WO disclosed
US-6034266-A ANTIINFLAMMTORY AGENTS, ANALGESICS, ANTIARTHRITIC AGENTS FUNDACAO OSWALDO CRUZ-FIOCRUZ (BR) 2000-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230131899-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID SNCA, PARK7, PRNP KDM4E 4800/4885MEN1 4376/4885KMT2A 4786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.